FDA approves Jardiance (empagliflozin) for the treatment of type 2 diabetes in children 10 years and older Read more
Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Read more
Soliris approved in China for the treatment of adults with refractory generalised myasthenia gravis Read more
INJECTAFER Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure Read more
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology Read more